Zuletzt veröffentlichtes Transkript: Reata Pharmaceuticals, Inc.
Manager | Titel | Alter | Seit |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01.09.22 |
Director of Finance/CFO | 60 | 26.09.23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01.09.22 |
Director/Board Member | - | 26.09.23 | |
Michael Dambach
BRD | Director/Board Member | - | 26.09.23 |
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,10% | 0 M€ | 0.00% | - | |
0,07% | 0 M€ | 0.00% | - | |
0,05% | 773 M€ | -.--% | - | |
0,04% | 509 M€ | -.--% |
% 1. Jan. | Kap. | |
---|---|---|
-3.30% | 102 Mrd. | |
+1.79% | 96.07 Mrd. | |
-1.22% | 21.66 Mrd. | |
-18.35% | 20.77 Mrd. | |
-8.33% | 18.53 Mrd. | |
-40.31% | 16.91 Mrd. | |
-26.84% | 13.79 Mrd. | |
+0.59% | 13.33 Mrd. | |
+20.86% | 10.94 Mrd. |